EWSR1 Peptide 
Datasheet
COA
MSDS
SHIP
Product Name :
EWSR1 Peptide Applications :
Blocking Background :
EWS is a nuclear RNA-binding protein. As a result of chromosome translocation, the EWS gene is fused to a variety of transcription factors, including ATF-1 in human neoplasias. In the Ewing family of tumors, the N-terminal domain of EWS is fused to the DNA-binding domain of various ETS transcription factors, including Fli-1, Erg, ETV1, E1AF and FEV. The EWS/Fli-1 chimeric protein acts as a more potent transcriptional activator than Fli-1 and can promote cell transformation. Two functional regions have been identified in EWS; an amino-terminal region (domain A), that has little transactivation activity but transforms efficiently when fused to Fli-1, and a distal region (domain B), which shows transactivation activity but transforms less efficiently when fused to Fli-1. Alternative Name :
RNA-binding protein EWS; EWS oncogene; Ewing sarcoma breakpoint region 1 protein; EWS Swiss-Prot :
Q01844 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide EWSR1. (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS5715 EWSR1 pAb.
EWSR1 Peptide Applications :
Blocking Background :
EWS is a nuclear RNA-binding protein. As a result of chromosome translocation, the EWS gene is fused to a variety of transcription factors, including ATF-1 in human neoplasias. In the Ewing family of tumors, the N-terminal domain of EWS is fused to the DNA-binding domain of various ETS transcription factors, including Fli-1, Erg, ETV1, E1AF and FEV. The EWS/Fli-1 chimeric protein acts as a more potent transcriptional activator than Fli-1 and can promote cell transformation. Two functional regions have been identified in EWS; an amino-terminal region (domain A), that has little transactivation activity but transforms efficiently when fused to Fli-1, and a distal region (domain B), which shows transactivation activity but transforms less efficiently when fused to Fli-1. Alternative Name :
RNA-binding protein EWS; EWS oncogene; Ewing sarcoma breakpoint region 1 protein; EWS Swiss-Prot :
Q01844 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide EWSR1. (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS5715 EWSR1 pAb.
Blocking peptide available as BS5715PP